CTA Junks Procter & Gamble Tax Refund Claim

CTA Junks Procter & Gamble Tax Refund Claim

Spotlight

Globe Recreates The Holiday Season With #ChristmasWeLove Live Pop-Up

Join Globe as they celebrate the holiday season with #ChristmasWeLove - a series of live digital pop ups featuring fun activities for your family and friends!

Republic Cement Launches Co-Processing Solution Amid PH Waste Management Crisis

Through ecoloop, Republic Cement aims to help address the waste management crisis of the country.

Recreate The Holidays Right At Home Best With Globe At Home Unli Plans

Make your virtual get-togethers possible with Globe At Home UNLI Plans!

SM – Pasay Tech Voc Scholarship Program Launched

With the launch of the SM - Pasay Tech-Voc Scholarship Program, a full tech-voc scholarship will be awarded to 20 students from financially challenged families.

The Court of Tax Appeals (CTA) has turned down a PHP42.09-million refund claim filed by Procter & Gamble Asia Pte. Ltd., the Singapore based company which has its regional operating headquarters in the Philippines.

In a 23-page decision dated November 29, the tax court’s Special Second Division Associate Justice Erlinda P. Uy said it has turned down the refund claim for alleged excess and unutilized input value-added tax (VAT) for failure of petitioner to show that its sales of services for the periods covering January 2005 to March 2005 and April 2005 to June 2005, qualify for VAT zero-rating.

Associate Justice Juanito Castaneda Jr. concurred with the decision.

The court said that in the absence of proof of inward remittance and proof that the same was paid for in acceptable foreign currency duly accounted for under the rules and regulations of the Bangko Sentral ng Pilipinas (BSP), it cannot consider for tax credits the transactions to the company’s clients, Procter & Gamble’s subsidiaries and affiliates in other countries.

The said transactions amounting to PHP421.853 million cannot thus be considered as zero-rated sales, the tax court said. (PNA)

Sara Orders Mandatory Use Of Face Shield In Public Areas

The use of face shields in public places in Davao City is now compulsory following an executive order from Mayor Sara Z. Duterte.

Army Helps NorMin Farmers With Alternative Market

With the opening of farmers’ market inside 4ID's Camp Evangelista, local farmers from Northern Mindanao can now profit more during the Yuletide season.

Philippines’ First Multi-Platform Game Show To Be Available Worldwide

Catch Robi Domingo and the PH’s pambansang gameshow “Game KNB” as it goes worldwide across multiple platforms!

SCG Achieved Growth In Profit From Its Operating Results For Q3 2020

Even amid the current health crisis, Siam Cement Group (SCG) achieved a 57% growth in profit for the Q3 of 2020.

Palace Welcomes LGU Initiative To Buy Covid-19 Vaccines

“We appreciate po and welcome the initiatives of LGUs na maglaan ng sariling pondo para makabili ng bakuna. Ang problema lang po talaga ay iyong availability…” says Presidential Spox Harry Roque.

Gov’t Agencies Seek To Raise Halal Consciousness In C. Visayas

The Depart of Agriculture - Central Visayas, along with several organizations, have sought to increase awareness on the production of halal-certified goods in the region.

Performances, Games Await Pinoy Fans In Brightwin’s Live Virtual Fan Meet

Join the ultimate bonding experience with "2gether" stars Bright Vachirawit and Win Metawin at their virtual fan meet on December 5, 5PM. Click the link below for more details:

PH Logs 232 New Covid-19 Recoveries, Tally Now At 399,005

Good news! Recovery rate in the Philippines is now at 91.9%!

Rep. Salceda Releases Statement On Jobless Rate Reduction In PH

“As a representative of a typhoon-ravaged province, I will tell you, we need urgent help. Our LGUs fiscal reserves are exhausted. We can no longer wait for 2021,” says Albay 2nd district Rep. Joey Sarte Salceda.

PRRD OKs Emergency Use Authorization For Covid-19 Drugs, Vaccines

President Rodrigo Duterte has approved the Emergency Use Authorization (EUA) for drugs and vaccines against COVID-19.